-Reuters
SVB Leerink Believes ShockWave Is Well-Positioned In Calcified Cardiovascular Market
SVB Leerink has initiated the coverage of ShockWave Medical Inc (NASDAQ:SWAV) with an Outperform rating and a $208 price target, implying an…
Walt Disney CEO Iger Says Co. Is ‘Not Engaged’ In Conversations Concerning Spinning Out ESPN
-Reuters
Related Posts
Amylyx Pharma Shares Volatile Over Last Few Mins. Following Circulation Of FDA Briefing Docs Ahead Of FDA Meeting On Co.’s Peripheral, Central Nervous System Drugs Panel
https://www.fda.gov/advisory-committees/peripheral-and-central-nervous-system-drugs-advisory-committee/updated-meeting-time-and-open-public-hearing-time-march-30-2022-meeting-peripheral-and-central#event-materials
Barclays Initiates Coverage On Fluence Energy with Overweight Rating, Announces Price Target of $41
Barclays analyst Moses Sutton initiates coverage on Fluence Energy (NASDAQ:FLNC) with a Overweight rating and announces Price Target of $41.